In 2005, the first GLP-1 got FDA approval to manage type 2 diabetes due to its ability to keep blood sugar stable, with others soon following
Our formulation uses 97% HCl berberine and is paired with curcumin for enhanced bioavailability and added anti-inflammatory support
While other GLP-1R agonists have shown promising outcomes in mitigating cancer progression, the association between some GLP-1R agonists and an increased risk of cancer remains a topic requiring more profound investigation
Neuroprotective Mechanisms There is increasing attention on BPC-157 for its interaction with neurological pathways
Evans, PhD, and Steven Cummings, MD warn that sarcopenia in older adults may be especially concerning, as it can contribute to hip fractures, disability, and increased mortality